CPT Knowledgebase - May 3, 2022

A patient with a neuroendocrine pancreatic tumor is on a monthly dose of octreotide administered by intramuscular (IM) injection. To report this service, is it appropriate to select the code based on the drug classification as a therapeutic and report code 96372? Or is it appropriate to select the code based on the intent as an anti-neoplastic and report code 96402?

To view the Official AMA answer and 1000s more like this:

CPT® Knowledge Base is a compendium of real life coding questions asked by the coding community and answered by CPT® coding experts.

Over 2900 questions and authoritative answers from the CPT® professionals at the AMA. Get specific answers to challenging coding questions, and search the knowledge base of others' real world questions.

Access to this feature is available in the following products:
  • AMA's CPT® Advanced Coding Pack

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.